Microsoft and Nokia have finally cleared a major hurdle in their plan for Microsoft to acquire Nokia handset operations and a significant portion of its patent portfolio, but not without conditions, say reports.
China’s Ministry of Commerce has approved the deal after forcing the parties to delay their anticipated closure date; the companies had originally looked to finalize the deal in the first quarter of this year.
While China is notorious for taking longer than some of its international counterparts to review mergers, the acquisition earned criticism from Chinese handset rivals, including Lenovo and ZTE, that relayed those concerns to Mofcom.
The majority of the concern, reports say, have to do with how the transaction will affect Nokia’s patent licensing fees. Similarly, the European Commission received opposition to the deal on the grounds that it could entice Nokia to charge higher licensing fees.
But in a statement released Tuesday, Nokia said that “no authority has challenged Nokia’s compliance with its FRAND undertakings related to standard-essential patents…or requested that Nokia make changes to its licensing program or royalty terms.”
Still, Microsoft reportedly offered to Chinese regulators to license its standard-essential patents on FRANT terms in addition to making non-exclusive licenses available to Android phones.
While China’s approval of the deal means the companies have progressed towards completing the acquisition, Nokia is facing challenges in India with a tax dispute that had Indian regulators require a $573 million guarantee before one of its manufacturing plants in the nation could be transferred to Microsoft.
Full Content: NDZet
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas